(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of -2.97% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Wave Life Sciences's revenue in 2025 is $104,939,000.On average, 8 Wall Street analysts forecast WVE's revenue for 2025 to be $8,365,938,663, with the lowest WVE revenue forecast at $5,394,694,865, and the highest WVE revenue forecast at $11,294,949,706. On average, 7 Wall Street analysts forecast WVE's revenue for 2026 to be $9,567,876,678, with the lowest WVE revenue forecast at $3,614,445,560, and the highest WVE revenue forecast at $14,226,581,030.
In 2027, WVE is forecast to generate $15,731,855,031 in revenue, with the lowest revenue forecast at $5,086,426,587 and the highest revenue forecast at $33,092,599,643.